Masashi Shimura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis.
Journal: Cancer science
Published: September 08, 2025
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: December 10, 2020
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 12, 2020
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: January 22, 2018
Reducing overestimation of the treatment effect by interim analysis when designing clinical trials.
Journal: Journal of clinical pharmacy and therapeutics
Published: October 04, 2017
Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.
Journal: Pharmaceutical statistics
Published: August 29, 2017
Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
Journal: Statistics in medicine
Published: December 08, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026